41126 Federal Register / Vol. 87, No. 131 / Monday, July 11, 2022 / Notices 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in paragraph 7 of 

the Act. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than July 26, 2022. 

A. Federal Reserve Bank of Atlanta 

(Erien O. Terry, Assistant Vice 

President) 1000 Peachtree Street NE, 

Atlanta, Georgia 30309, or electronically 

to Applications.Comments@atl.frb.org: 

1. The George J. White Revocable 

Trust, Robert D. White, as trustee, the 

Marilyn M. White Revocable Trust, 

Marilyn M. White, as trustee, Robert D. 

White, and Amy D. White, all of Mount 

Dora, Florida; George J. White III, 

Decatur, Georgia; Anna C. White, 

Asheville, North Carolina; and Amelia 

M. White, Athens, Georgia; a group 

acting in concert to retain voting shares 

of FNBMD Bancshares, Inc., and thereby 

indirectly retain voting shares of The 

First National Bank of Mount Dora, both 

of Mount Dora, Florida. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2022–14718 Filed 7–8–22; 8:45 am] 

BILLING CODE 6210–01–P 

GENERAL SERVICES 

ADMINISTRATION 

[Notice–MA–2022–08; Docket No. 2022– 

0002; Sequence No.15] 

Relocation Allowances—Extended 

Waiver of Certain Federal Travel 

Regulation (FTR) Provisions During 

the COVID–19 Pandemic 

AGENCY: Office of Government-wide 

Policy (OGP), General Services 

Administration (GSA). 

ACTION: Notice of GSA Bulletin FTR 22– 

07, Extended waiver of certain Federal 

Travel Regulation (FTR) provisions 

during the Coronavirus Disease 2019 

(COVID–19) pandemic. 

SUMMARY: This GSA Bulletin FTR 22–07 

informs agencies that certain provisions 

of the FTR governing official relocation 

travel and renewal agreement travel 

(RAT) may continue to be temporarily 

waived for the period of time stated in 

the bulletin. This bulletin also rescinds 

an expiring GSA bulletin pertaining to 

relocation allowances during the 

pandemic and re-establishes 

information therein via this new 

bulletin. 

DATES: Applicability Date: This notice is 

retroactively effective for official 

relocation travel performed after March 

13, 2019, one year prior to the date of 

the Presidential national emergency 

proclamation concerning COVID–19. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Rick Miller, Senior Policy Analyst, 

Office of Government-wide Policy, 

Office of Asset and Transportation 

Management, at 202–501–3822, or 

travelpolicy@gsa.gov. Please cite Notice 

of GSA Bulletin FTR 22–07. 

SUPPLEMENTARY INFORMATION:

Background: Federal agencies 

authorize relocation entitlements to 

those individuals listed at FTR § 302– 

1.1 and those assigned under the 

Government Employees Training Act 

(GETA) (5 U.S.C. chapter 41). Since the 

Presidential national emergency 

proclamation issued March 13, 2020 

concerning COVID–19, the pandemic 

has resulted in various travel-related 

disruptions to relocating employees. 

Accordingly, GSA issued Bulletin 22–04 

(86 FR 73279 December 27, 2021) to 

rescind FTR 21–04 (86 FR 14326 March 

15, 2021) (which rescinded and 

replaced related GSA Bulletins FTR 20– 

06 (85 FR 23029 April 24, 2020) and 

FTR 21–02 (85 FR 59311 September 21, 

2020)), to allow agencies to determine 

whether to implement waivers of time 

limits established by the FTR for 

completion of all aspects of relocation, 

temporary storage of household goods 

(HHG) shipments, house hunting trips 

(HHT), and time remaining in a second 

tour of duty upon return from renewal 

agreement travel (RAT). GSA Bulletin 

FTR 22–04 and the waiver provisions 

therein, is set to expire on June 30, 

2022. 

As COVID–19 has continued to 

produce uncertainty and create 

difficulties for relocating individuals, 

GSA is extending certain FTR waivers 

by rescinding GSA Bulletin FTR 22–04 

and re-establishing the information 

therein by issuance of this new GSA 

Bulletin FTR 22–07 with a later 

expiration date. GSA Bulletin FTR 20– 

06, FTR 21–02 and FTR 21–04 remain 

rescinded. The new GSA Bulletin FTR 

22–07 can be viewed at https://

www.gsa.gov/ftrbulletins. 

Dated: June 30, 2022. 

Krystal J. Brumfield, 

Associate Administrator, Office of 

Government-wide Policy. 

[FR Doc. 2022–14716 Filed 7–8–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

intention of the Agency for Healthcare 

Research and Quality (AHRQ) to request 

that the Office of Management and 

Budget (OMB) approve the proposed 

information collection project ‘‘Medical 

Expenditure Panel Survey (MEPS) 

COVID–19 Changes.’’ 

DATES: Comments on this notice must be 

received by September 9, 2022. 

ADDRESSES: Written comments should 

be submitted to: Doris Lefkowitz, 

Reports Clearance Officer, AHRQ, by 

email at doris.lefkowitz@AHRQ.hhs.gov. 

Copies of the proposed collection 

plans, data collection instruments, and 

specific details on the estimated burden 

can be obtained from the AHRQ Reports 

Clearance Officer. 

FOR FURTHER INFORMATION CONTACT: 

Doris Lefkowitz, AHRQ Reports 

Clearance Officer, (301) 427–1477, or by 

email at doris.lefkowitz@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Proposed Project 

‘‘Medical Expenditure Panel Survey 

(MEPS) COVID–19 Changes’’ 

The Medical Expenditure Panel 

Survey (MEPS) consists of the following 

three components and has been 

conducted annually since 1996: 

• Household Component (MEPS–HC): 

A sample of households participating in 

the National Health Interview Survey 

(NHIS) in the prior calendar year are 

interviewed 5 times over a 2 and onehalf (2.5) year period. These 5 

interviews yield 2 years of information 

on use of, and expenditures for, health 

care, sources of payment for that health 

care, insurance status, employment, 

health status and health care quality. 

• Medical Provider Component 

(MEPS–MPC): The MEPS–MPC collects 

information from medical and financial 

records maintained by hospitals, 

physicians, pharmacies and home 

health agencies named as sources of 

care by household respondents. 

• Insurance Component (MEPS–IC): 

The MEPS–IC collects information on 

establishment characteristics, insurance 

offerings and premiums from 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 131 / Monday, July 11, 2022 / Notices 41127 

employers. The MEPS–IC is conducted 

by the Census Bureau for AHRQ and is 

cleared separately. 

This request is for the MEPS–HC only. 

The OMB Control Number for the 

MEPS–HC and MEPS–MPC is 0935– 

0118, which was last approved by OMB 

on November 18, 2020, and will expire 

on November 30, 2023. 

The purpose of this request is to 

update questions related to COVID–19 

in MEPS. New round 1 questions on 

COVID–19 capture information on 

whether household members have ever 

had COVID–19 and when they most 

recently had COVID–19. Follow-up 

questions in later rounds determine if 

household members have had COVID– 

19 in the interview reference period. 

This study is being conducted by 

AHRQ through its contractors, Westat 

and RTI International, pursuant to 

AHRQ’s statutory authority to conduct 

and support research on healthcare and 

on systems for the delivery of such care, 

including activities with respect to the 

cost and use of health care services and 

with respect to health statistics and 

surveys. 42 U.S.C. 299a(a)(3) and (8); 42 

U.S.C. 299b–2. 

Method of Collection 

The questions will be asked of all 

MEPS sample members with a single 

household respondent reporting for the 

household. The first two questions serve 

as gate questions and only respondents 

who report having a COVID–19 

diagnosis in the relevant time period 

will receive follow-up questions about 

the timing of their most recent infection. 

These questions will be administered in 

the existing Priority Conditions 

Enumeration section of MEPS, which 

includes a similar series of questions 

about whether household members have 

ever been diagnosed with certain 

medical conditions. 

Historically, MEPS has been 

conducted using Computer Assisted 

Personal Interviewing (CAPI) where 

field interviews conduct interviews 

with household respondents in person. 

However, MEPS is currently being 

conducted via multiple modes, 

including face-to-face, phone, and 

virtual interviewing, due to the ongoing 

COVID–19 pandemic. 

The information collected on COVID– 

19 diagnoses will undergo editing and 

be reviewed for data quality, including 

consistency with publicly available 

sources of data on COVID–19 infections. 

Additionally, the resulting variables 

will be included on the annual MEPS 

full-year consolidated public use data 

files after being assessed for any 

potential disclosure concerns. 

The new CAPI questions collecting 

information about COVID–19 will be 

folded into the regular processing 

stream of MEPS data to produce 

estimates of health care utilization and 

expenditures. The information collected 

on COVID–19 diagnoses will be used to 

compare healthcare utilization and 

expenditures between those who have 

had confirmed COVID–19 and those 

who have not. Additionally, the 

information collected on the timing of 

recent infections can be used to either 

include or exclude recent infections 

from calendar year or round-specific 

estimates of healthcare utilization and 

expenditures. This allows researchers to 

examine both shorter-term and longerterm impacts of a COVID–19 diagnosis 

on healthcare utilization and 

expenditures. 

Estimated Annual Respondent Burden 

Exhibit 1 shows the estimated 

annualized burden hours for 

respondents’ time to participate in this 

research. The addition of several 

questions related to COVID–19 adds 

minimal burden in hours and costs to 

the core CAPI interview, estimated to 

add 1 minute per interview and a total 

of 222 burden hours. 

Exhibit 2 shows the estimated 

annualized cost burden associated with 

respondents’ time to participate in this 

research. The total cost burden is 

estimated to be $6,218 annually. 

EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS

Activity Number of 

respondents 

Number of 

responses per 

respondent 

Hours per 

response 

Total burden 

hours 

COVID–19 questions included in the MEPS questionnaire .......................... 13,338 * 1 1/60 222 

* While the expected number of responding units for the annual estimates is 12,804, it is necessary to adjust for survey attrition of initial respondents by a factor of 0.96 (13.338 = 12/804/0.96). 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN

Activity Number of 

respondents 

Total burden 

hours 

Average 

hourly 

wage rate * 

Total cost 

burden 

COVID–19 questions included in the MEPS questionnaire .......................... 13,338 222 $28.01 $6,218 

* Based upon mean hourly wage, ‘‘May 2021 National Occupational Employment and Wage Estimates United States,’’ U.S. Department of 

Labor, Bureau of Labor Statistics, retrieved at https://www.bls.gov/oes/current/oes_nat.htm#00-0000. 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, 44 U.S.C. 3501–3520, 

comments on AHRQ’s information 

collection are requested with regard to 

any of the following: (a) whether the 

proposed collection of information is 

necessary for the proper performance of 

AHRQ’s health care research and health 

care information dissemination 

functions, including whether the 

information will have practical utility; 

(b) the accuracy of AHRQ’s estimate of 

burden (including hours and costs) of 

the proposed collection(s) of 

information; (c) ways to enhance the 

quality, utility and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: July 5, 2022. 

Mamatha Pancholi, 

Acting Chief of Staff, Chief Data Officer. 

[FR Doc. 2022–14637 Filed 7–8–22; 8:45 am] 

BILLING CODE 4160–90–P 


khammond on DSKJM1Z7X2PROD with NOTICES